The cellular uptake and efflux of glucose is mediated by multipass transporters which are differentially expressed between tissues.
Glut family transporters are required for importing glucose into cells. They are most highly expressed in glucose-dependent organs such as brain, skeletal muscle, and kidney.
SGLT transporters are highly expressed in the kidney or small intestine. SGLT2 mediates glucose reabsorption from the renal glomerular filtrate and is an important pharmaceutical target for treatment of hyperglycemia.
Insulin is an anabolic peptide hormone that is secreted by pancreatic beta cells and promotes cellular glucose uptake and glycogen storage. It binds to the Insulin R which triggers signaling through IRS1 and IRS2. Dysregulation of insulin production or action is the defining characteristic of Type 1 and Type 2 diabetes, respectively.
- Insulin System Antibodies and Conjugates >
- Insulin System Bioactive Proteins >
- Insulin System ELISA Kits >
- Insulin Simple Plex™ Assay >
- Insulin System Proteome Profiler® Antibody Arrays >
- Insulin and Insulin-like Receptor Inhibitors and Activators >
Glucagon is a catabolic peptide hormone secreted by pancreatic alpha cells during times of fasting. It signals through Glucagon R and counterbalances Insulin’s effects by limiting Insulin secretion and promoting hepatic glycogenolysis.
Intracellular Glucose Metabolism
Internalized glucose is catabolized through glycolysis or converted to glycogen for energy storage, primarily in the liver. The expression of glucose and glycogen-metabolizing enzymes is controlled by transcription factors that are responsive to intracellular glucose levels.
Proteins and lipids can be non-enzymatically modified by glycation to generate advanced glycation end products (AGEs) such as carboxymethyl lysine (CML). The binding of AGE-modified macromolecules to RAGE and scavenger receptors triggers widespread inflammatory reactions. Glycation is accelerated by hyperglycemia, oxidative stress, and aging.